Publication | Closed Access

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Hematological MalignancyOncologyContinuous Lenalidomide MaintenanceHematologyMyeloid NeoplasiaMultiple MyelomaMedicineRadiation OncologyMinimal Residual DiseaseHealth Sciences